Search
for
Sort by
Research 481–510 of 880
- Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- The Safety and Efficacy of a Novel Saw Palmetto ( <i>Serenoa repens</i> ) Extract for Promoting Hair Growth in Adults With Self‐Perceived Thinning Hair: 180‐Day Results
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- Cancer-Related Alopecia Risk and Treatment
- Focused Review on Metal Nanoparticles in Hair Regeneration and Alopecia: Insights into Mechanisms, Assessment Techniques, Toxicity, Regulatory and Intellectual Property Perspectives
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Recent Advances in Drug Development for Hair Loss
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Advancements in non-laser energy-based devices in trichology: A comprehensive review
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Identification and characterization of alopecia areata subgroups regarding quality of life impairment based on demographic, clinical, psychological, and social factors
- An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Topical solutions for androgenetic alopecia: evaluating efficacy and safety
- Hair
- Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel
- Immune niches for hair follicle development and homeostasis
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations